₹399.65
2.05 (0.52%) - 24 Jun 2025 04:29 PMMedicamen Biotech Limited is engaged in manufacturing and marketing of pharmaceutical formulations in overseas and domestic markets. It is a manufacturer and supplier of a range of products, such as tablets, capsules, liquid syrup and dry syrup (beta lactum and non beta lactum), and ointment. Its product offerings include Acarbrose Tablets 50 milligram, Acetazolamide Tablet 250 milligram BP, Amitriptyline Hcl Tablet 25 milligram, Amlodipine Besylate Tablet 10 milligram, and Sulfadoxine and Anti Malarial Kit. As of March 31, 2012, its production capacity under beta lactum included tablets (eight million per day), capsules (one million per day), oral liquid (4600 liters per day), and dry syrup (6000 kilogram per day). Its production capacity under non beta lactum included tablets (one million per day), capsules (one million per day), liquid (1300 liters per day), and dry syrup (50,000 bottles per day). The Company has two manufacturing at Bhiwadi and Haridwar.
Industry - Pharmaceuticals & Drugs
* Please refer to the Standalone data if Consolidated financial data for the company is not available.
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED
| All logos and Trademarks registered with their respective owners.
